Inovio Pharmaceuticals, Inc. (INO) vs Veraxa Biotech AG (VRXA)

Inovio Pharmaceuticals, Inc. INO 1.22 −15.86%
Veraxa Biotech AG VRXA 0.95 0.00%

Inovio Pharmaceuticals, Inc. and Veraxa Biotech AG are both Biotechnology companies. Veraxa Biotech AG is the larger, with a market value of $140.4M against $125.6M — 1.1× the size.

Metric	INO	VRXA	Biotechnology median
P/E	n/m	—	10.60
P/S	258.10	—	9.40
P/B	22.78	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	206.11	—	9.02
Earnings yield	(94.67%)	—	(32.88%)
Free cash flow yield	(80.41%)	—	(23.13%)

Metric	INO	VRXA	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(409.87%)	—	(51.96%)
Return on assets	(114.64%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	INO	VRXA	Biotechnology median
Revenue growth (TTM)	(54.82%)	—	6.76%
EPS growth (last fiscal year)	54.18%	—	29.88%
Revenue growth, 5-year CAGR	(61.18%)	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	INO	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	1.00	—	4.97
Net debt to EBITDA	0.70	—	1.01

Metric	INO	VRXA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	INO	VRXA	Biotechnology median
Market cap	125.63m	140.35m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack